Wildlife Service Scientist/Sleuths

ASHLAND, OREG.—The pharoah in the biblical story of Joseph suffered through seven lean years; biochemist Ken Goddard’s dry spell lasted even longer. For nine years, this U.S. Fish & Wildlife Service scientist was a voice crying in the wilderness, trying to convince the powers-that-be that the nation desperately needs a forensic laboratory to combat the growing illegal trade in wildlife products. And for most of those nine years, Goddard found his efforts stymied by tight budgets

Written byVirginia Morrell
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

ASHLAND, OREG.—The pharoah in the biblical story of Joseph suffered through seven lean years; biochemist Ken Goddard’s dry spell lasted even longer. For nine years, this U.S. Fish & Wildlife Service scientist was a voice crying in the wilderness, trying to convince the powers-that-be that the nation desperately needs a forensic laboratory to combat the growing illegal trade in wildlife products. And for most of those nine years, Goddard found his efforts stymied by tight budgets and doubting bureaucrats. So for Goddard, the current promise of years of plenty is doubly sweet.

Seven months ago, the F&WS’s forensic laboratory—the first of its kind in the world—finally opened its doors in Ashland, Oreg., with Goddard as director. He’s still looking for more scientific sleuths to fill out his staff, but that’s a minor hurdle compared to what he’s been through. “I always believed I would win this,” he says, “but when ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies